Cost-benefit of minimally invasive staging of non-small cell lung cancer: a decision tree sensitivity analysis. [electronic resource]
Producer: 20110203Description: 1564-70 p. digitalISSN:- 1556-1380
- Australia
- Biopsy, Fine-Needle
- Carcinoma, Non-Small-Cell Lung -- diagnostic imaging
- Cost-Benefit Analysis
- Decision Trees
- Endosonography
- Fluorodeoxyglucose F18
- Health Care Costs
- Humans
- Lung Neoplasms -- diagnostic imaging
- Mediastinoscopy
- Neoplasm Staging -- economics
- Prognosis
- Radiopharmaceuticals
- Sensitivity and Specificity
- Tomography, Emission-Computed
- Tomography, X-Ray Computed
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.